Lv01
0 积分 2024-11-30 加入
CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia
3个月前
已完结
Unlocking the Potential of CAR-NK Cell Therapy: Overcoming Barriers and Challenges in the Treatment of Myeloid Malignancies
3个月前
已完结
Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: the multi-center efficacy and safety interim analysis
3个月前
已完结
Novel strategies to manage CAR-T cell toxicity
5个月前
已完结
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
5个月前
已完结
Abstract PR14: CD123CAR displays clinical activity in relapsed/refractory (r/r) acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN): Safety and efficacy results from a phase 1 study
5个月前
已完结
Acute myeloid leukaemia
5个月前
已完结
The mechanisms and countermeasures for CAR-T cell expansion and persistence deficiency
5个月前
已完结
皖公网安备34019202002308
